B. Willems

TL;DR: This study reveals that by using appropriate screening methods, a large proportion of memory B cells can be isolated that produce mAbs with HIV-1 neutralizing activity, and three of these mAbs show unusual breadth of neutralization and therefore add to the current panel of HIV- 1 neutralizing antibodies with potential for passive protection and template-based vaccine design.

TL;DR: In this paper , the authors investigated whether undiagnosed infections occurred among men attending a Belgian sexual health clinic in May 2022, and they found that certain cases of monkeypox remain unddiagnosed and suggest that testing and quarantining of individuals reporting symptoms may not suffice to contain the outbreak.

TL;DR: The authors suggest that the results of a research project on the prevalence of sera collected from HIV-1 positive people in Cameroon Gabon Ivory Coast and Kenya which are reactive to a genetically divergent HIV-2 V3 peptide isolate (ANT70) and peptides obtained from 3 other HIV- 1 isolates should prompt further investigation in mapping antigenic diversity in Africa.

TL;DR: It is confirmed that three isolates are sufficient to allow identification of broad cross‐neutralizing sera in primary HIV‐1 isolates belonging to different genetic groups and clades.

TL;DR: This study shows that a considerably less expensive but sufficiently accurate HIV-1 antigen capture assay can be developed to monitor HIV- 1 (group M and O), SIVcpv and SIVmnd antigen in the supernatants of virus cultures.